Videos

The Next Evolution of Biomanufacturing Technology

NevoLine platform offers solutions for various applications such as viral vaccines, gene therapies, and oncolytic viruses

By: Kristin Brooks

Managing Editor, Contract Pharma



The NevoLine biomanufacturing platform offers a disruptive approach to achieve cost-effective viral production. The technology combines principles of process intensification, chaining, and automation in self-contained modules to reduce facility footprint, capital, and operational expenditures. The platform offers solutions for various applications such as viral vaccines, gene therapies, and oncolytic viruses.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters